ADDYI

Brand name authorized in: United States

Active ingredients

The drug ADDYI contains one active pharmaceutical ingredient (API):

1 Flibanserin
UNII 37JK4STR6Z - FLIBANSERIN

Flibanserin is a multifunctional serotonin agonist and antagonist used for the treatment of premenopausal women with hypoactive sexual desire disorder. In vitro, flibanserin acts as an agonist on 5-HT1A receptors and an antagonist on 5-HT2A receptors. It also has moderate antagonist activities at the 5-HT2B, 5-HT2C, and dopamine D4 receptors.

Read about Flibanserin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code
Group title
Classification
Flibanserin
G Genito urinary system and sex hormones → G02 Other gynecologicals → G02C Other gynecologicals → G02CX Other gynecologicals
Discover more medicines within G02CX02

Medication package inserts

Below package inserts are available for further reading:

Title
Type
Country
Structured product labeling (SPL/PLR)
US

Unique identifiers

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country
Identification scheme
Identifier(s)
CA
Health Products and Food Branch
Identifier(s): 02473550
US
FDA, National Drug Code
Identifier(s): 58604-214